Mood Disorders News

Patient expectancy significantly mediated placebo effects in antidepressant trials, according to recent findings.

Individuals with depression who were in higher occupational levels had poorer treatment response and higher rates of treatment-resistant depression, according to findings presented at the European College of Neuropsychopharmacology Congress.

Individuals with a sibling with schizophrenia were approximately ten times more likely to develop the disorder and had increased risk for bipolar disorder and other mental health disorders, according to findings presented at the European College of Neuropsychopharmacology Congress.

Erythropoietin, commonly used as a performance-enhancing drug in sports, improved cognitive functioning among individuals with unipolar or bipolar depression, according to findings presented at the European College of Neuropsychopharmacology Congress.

A literature review indicated that FDA-approved hypnotic medications were associated with increased risk for suicidal ideation.

Pfizer recently announced the launch of Moodivator, a new iPhone application designed to support, encourage and motivate individuals with depression.

Postpartum psychosis most frequently occurs in mothers with bipolar disorder, but is often missed due to rarity and lack of research, according to a recent review.

Sertraline may effectively prevent depressive disorders following traumatic brain injury, according to recent findings.

Restricting time in bed to 6 hours for 2 weeks did not improve antidepressant treatment response among individuals with major depressive disorder, according to recent findings.

The upcoming U.S. Psychiatric and Mental Health Congress Conference will fulfill this year’s theme of “mental wellness” through a plethora of offerings, including educational sessions, networking events, poster presentations, exhibitions and more